![Xiao Hui Ji](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Xiao Hui Ji
Director/Board Member at
LEGEND BIOTECH CORPORATION
Net worth: 359 378 $ as of 2026-07-30
Profile
Xiao Hui Ji is the founder of Elpiscience Biopharma Ltd., founded in 2017, serving as Chairman & Chief Executive Officer.
Dr. Ji was the founder of PharmaLegacy Laboratories (Shanghai) Co., Ltd., founded in 2008, serving as Chief Executive Officer from 2008 to 2012.
Dr. Ji is the founder of Elpiscience Biopharmaceuticals, Inc., founded in 2017, serving as Chairman & Chief Executive Officer.
Dr. Ji currently works as an Independent Director at Legend Biotech Corp.
since 2020.
Former jobs include Director at The BayHelix Group from 2008 to 2013, Vice President-Business Development at Roche Holding AG from 2013 to 2016, and Partner at LAV Management Co., Ltd. from 2017 to 2020.
Education includes an MBA from The University of Chicago, a doctorate from The University of Sheffield, and a doctorate from China Medical University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LEGEND BIOTECH CORP. 0.01% | 2026-03-17 | 38,747 ( 0.01% ) | 359 378 $ | 2026-07-30 |
Xiao Hui Ji active positions
| Companies | Position | Start |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Director/Board Member | 2020-04-30 |
Elpiscience Biopharma Ltd.
 Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Develops cutting-edge immunotherapies to fight cancer | Chief Executive Officer | 2017-05-31 |
Former positions of Xiao Hui Ji
| Companies | Position | End |
|---|---|---|
LAV Management Co., Ltd.
 LAV Management Co., Ltd. Investment ManagersFinance LAV invests in companies located in China and the United States. The firm targets companies operating in the fields of biopharmaceuticals, human therapeutics, medical devices and diagnostics. It provides financing for seed, early and later stage capital requirements. | Corporate Officer/Principal | 2020-04-30 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 2016-11-30 |
The BayHelix Group
 The BayHelix Group Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit professional organization | Director/Board Member | 2012-12-31 |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
 PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical research and development company that focuses on preclinical pharmacology & pharmacodynamics evaluation services | Chief Executive Officer | 2011-12-31 |
Elpiscience Biopharmaceuticals, Inc.
 Elpiscience Biopharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies for oncology and autoimmune diseases | Chief Executive Officer | - |
Training of Xiao Hui Ji
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
70
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Sheffield
 The University of Sheffield Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
China Medical University
 China Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV invests in companies located in China and the United States. The firm targets companies operating in the fields of biopharmaceuticals, human therapeutics, medical devices and diagnostics. It provides financing for seed, early and later stage capital requirements. | Finance |
The BayHelix Group
The BayHelix Group Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit professional organization | Commercial Services |
Legend Biotech Corp.
 Legend Biotech Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which engages in the discovery and development of novel cell therapies for oncology | Health Technology |
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Develops cutting-edge immunotherapies to fight cancer | Health Technology |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical research and development company that focuses on preclinical pharmacology & pharmacodynamics evaluation services | Commercial Services |
Elpiscience Biopharmaceuticals, Inc.
Elpiscience Biopharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies for oncology and autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Xiao Hui Ji
